Ad is loading...
GABIX
Price
$53.60
Change
-$0.28 (-0.52%)
Updated
Nov 15 closing price
VSMPX
Price
$265.08
Change
-$3.50 (-1.30%)
Updated
Nov 15 closing price
Ad is loading...

GABIX vs VSMPX

Header iconGABIX vs VSMPX Comparison
Open Charts GABIX vs VSMPXBanner chart's image
Gabelli Asset I
Price$53.60
Change-$0.28 (-0.52%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Instl Pls
Price$265.08
Change-$3.50 (-1.30%)
VolumeN/A
CapitalizationN/A
GABIX vs VSMPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GABIX vs. VSMPX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GABIX is a StrongBuy and VSMPX is a StrongSell.

FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 1.73T vs. GABIX (1.66B). VSMPX pays higher dividends than GABIX: VSMPX (1.36) vs GABIX (0.52). GABIX was incepted earlier than VSMPX: GABIX (17 years) vs VSMPX (10 years). GABIX is a more actively managed with annual turnover of: 4.00 vs. VSMPX (2.00). GABIX has a lower initial minimum investment than VSMPX: GABIX (500000) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 30.55 vs. GABIX (10.93). VSMPX return over 5 years is better than : 83.80 vs. GABIX (-6.05).
GABIXVSMPXGABIX / VSMPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years10 years-
Gain YTD10.97322.43749%
Front LoadN/AN/A-
Min. Initial Investment5000001000000001%
Min. Initial Investment IRAN/AN/A-
Net Assets1.66B1.73T0%
Annual Yield % from dividends0.521.3639%
Returns for 1 year10.9330.5536%
Returns for 3 years-15.7419.95-79%
Returns for 5 years-6.0583.80-7%
Returns for 10 years-17.71N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MS134.061.63
+1.23%
Morgan Stanley
OLN41.39-0.43
-1.03%
Olin Corp
SPNS28.00-0.56
-1.96%
Sapiens International Corp
RVNC4.17-0.14
-3.25%
Revance Therapeutics
VTGN2.63-0.10
-3.66%
VistaGen Therapeutics